Saturday March 20 2010 |
Biotechnology feed
|
All feeds
Home
Marketing Services
Antibodies
Careers
Directories
Drugs
Events
Genes
InDepth
News
Reports
Videos
A-Z
Business
Health
Drugs
Sources
Americas
Europe
Asia
Cancer
Cardio-
Diabetes
Bird Flu
Swine Flu
Summaries
Post News
Search
BioNews - BioPortfolio's News Portal
Metabolic Disorders News and Headlines
Sign-up to BioPortfolio's
Metabolic Disorders news alerts
.
Subscribe to
BioWatch News Email alerts
-
open
BioWatch PDF brochure
.
Publish your news
using BioNewsCast
- open
BioNewsCast PDF brochure
.
Treatment methods for the different types of psoriasis
Irish Medical Times:
similar ...
Research and Markets: Diabetes R & D Pipeline Reveals: 11Beta-HSD1 Inhibitors Are Undergoing Development for the Treatment of ..
PR inside:
similar ...
Research and Markets: Diabetes R & D Pipeline Reveals: 11Beta-HSD1 Inhibitors Are Undergoing Development for the Treatment of Diabetes by 10 Companies
Street Insider:
similar ...
Diabetes R & D Pipeline: 11beta-HSD1 Inhibitors
Research and Markets:
similar ...
Arterial stiffness may be involved in development of diabetes
Irish Medical Times:
similar ...
Early invasive strategy for acute coronary patients
Irish Medical Times:
similar ...
Efficacy of continued alendronate for fractures in women
Irish Medical Times:
similar ...
High Cholesterol, Diabetes Lead Drug Spending for the Elderly
Newswise:
similar ...
Rhythm Pharma Gets $21M A Round to Target Obesity, Diabetes
Xconomy:
similar ...
Leptin Shows Advantages Over Insulin in Type 1 Diabetes
Modern Medicine:
similar ...
Ipsen Grants Rhythm Pharmaceuticals Obesity Treatment Licence; Ipsen will Receive up to $
BioSpace:
similar ...
Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders
Pharma Live:
similar ...
Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders
SmartBrief:
similar ...
Ipsen, Rhythm Sign License Agreement For Programs In Metabolic Disorders
Pharmaceutical Business Review:
similar ...
Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders
NewsBlaze:
similar ...
Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders
Genetic Engineering News:
similar ...
Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders
Genetic Engineering News:
similar ...
Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders
Genetic Engineering News:
similar ...
Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders
Therapeutics Daily:
similar ...
Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders
PharmiWeb:
similar ...
